`

Crossject

Pharmaceutical Manufacturing

Specialities :
Injection sans aiguile and traitements d'urgence
Sign Up to View More
revenue-icon Revenue
101M - 500M
funding-icon Total Funding
$7.59M
size-icon Size
51 - 200
About Us
Org Charts
Employees
Buyer Intent
Tech Stack
Jobs

Frequently Asked Questions About Crossject

What does Crossject do?+

Crossject SA (Euronext: ALCJ; www.crossject.com) is an emerging specialty pharma company based in France and the U.S. It is in advanced regulatory development for ZEPIZURE, an epileptic rescue therapy, for which it was awarded a $60 million contract with the U.S. Biomedical Advanced Research and Development Authority (BARDA). ZEPIZURE is based on the Companys award-winning needle-free autoinjector ZENEO, designed to enable patients and untrained caregivers to easily and instantly deliver emergency medication via intramuscular injection on bare skin or even through clothing. The Companys other products in development include rescue therapies for allergic shocks, adrenal insufficiencies, opioid overdose and asthma...

What are Crossject's specialties? +

Injection sans aiguile and traitements d'urgence

What is Crossject's industry? +

Crossject operates in the Pharmaceutical manufacturing industry.

What is Crossject's revenue? +

Crossject's revenue is 101m - 500m

What is Crossject's company size? +

Crossject has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Sign Up For Free
Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Sign Up For Free
Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.

Sign Up For Free